TB Research

Systematic Review of Mutations Associated with Isoniazid Resistance Points to Continuing Evolution and Subsequent Evasion of Molecular Detection, and Potential for Emergence of Multidrug Resistance in Clinical Strains of Mycobacterium tuberculosis

Siavash Valafar

Antimicrobial Agents and Chemotherapy · 2020-12

Abstract

) associated with INH resistance and identified 59 loci (common to this and previous reviews) as a reliable basis for molecular diagnostics. Including all observed mutations provides a cumulative sensitivity of 85.6%. In 14.4% of resistant isolates, no mechanism of resistance was detected, making them likely to escape molecular detection, and in the case of INH monoresistance, likely to convert to multidrug-resistant TB (MDR-TB). Integrating the information cataloged in this study into current diagnostic tools is essential for combating the emergence of MDR-TB, and its exclusion can lead to an unintended selection against common mechanisms and to diversifying evolution. Observation of many low-frequency resistance-conferring mutations points to an advantage of whole-genome sequencing (WGS) for diagnostics. Finally, I provide five recommendations for future diagnostic platforms.

MeSH terms

  • Mycobacterium tuberculosis
  • Tuberculosis
  • Evasion (ethics)
  • Isoniazid
  • Virology
  • Biology
  • Multiple drug resistance
  • Outbreak
  • Extensively drug-resistant tuberculosis
  • Drug resistance
  • Microbiology
  • Medicine